Sign inGet started

ARCH Venture Partners VIII, L.P.

Insider CIK 1616176 · MTCR 10% owner · SNNA 10% owner · CDAK 10% owner · FIXX 10% owner · DNLI 10% owner · SRRK 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CDAK Codiak BioSciences, Inc. P Buy deriv2022-09-132022-09-155,000,000— $05,000,000SEC↗
CDAK Codiak BioSciences, Inc. P Buy2022-09-132022-09-155,000,000$1.50 $7.50M8,854,098SEC↗
CDAK Codiak BioSciences, Inc. C Conversion deriv2020-10-162020-10-206,500,000— $00SEC↗
CDAK Codiak BioSciences, Inc. C Conversion deriv2020-10-162020-10-2013,950,000— $00SEC↗
CDAK Codiak BioSciences, Inc. C Conversion deriv2020-10-162020-10-201,320,097— $00SEC↗
CDAK Codiak BioSciences, Inc. C Conversion deriv2020-10-162020-10-203,000,000— $00SEC↗
CDAK Codiak BioSciences, Inc. C Conversion deriv2020-10-162020-10-202,333,333— $00SEC↗
CDAK Codiak BioSciences, Inc. C Conversion2020-10-162020-10-20831,521— $0831,521SEC↗
CDAK Codiak BioSciences, Inc. C Conversion2020-10-162020-10-20191,721— $01,350,195SEC↗
CDAK Codiak BioSciences, Inc. P Buy2020-10-162020-10-20235,000$15.00 $3.52M2,503,903SEC↗
CDAK Codiak BioSciences, Inc. C Conversion2020-10-162020-10-201,784,572— $01,848,535SEC↗
CDAK Codiak BioSciences, Inc. C Conversion2020-10-162020-10-20326,953— $01,158,474SEC↗
CDAK Codiak BioSciences, Inc. C Conversion2020-10-162020-10-20420,368— $02,268,903SEC↗
MTCR Metacrine, Inc. C Conversion deriv2020-09-182020-09-221,960,784— $00SEC↗
MTCR Metacrine, Inc. C Conversion deriv2020-09-182020-09-22472,251— $00SEC↗
MTCR Metacrine, Inc. C Conversion deriv2020-09-182020-09-22138,734— $00SEC↗
MTCR Metacrine, Inc. C Conversion deriv2020-09-182020-09-22138,734— $00SEC↗
MTCR Metacrine, Inc. C Conversion2020-09-182020-09-22138,734— $02,571,769SEC↗
MTCR Metacrine, Inc. P Buy2020-09-182020-09-22210,000$13.00 $2.73M2,781,769SEC↗
MTCR Metacrine, Inc. P Buy2020-09-182020-09-2220,000$13.00 $260.0K158,734SEC↗
MTCR Metacrine, Inc. C Conversion2020-09-182020-09-22138,734— $0138,734SEC↗
MTCR Metacrine, Inc. C Conversion2020-09-182020-09-22472,251— $02,433,035SEC↗
MTCR Metacrine, Inc. C Conversion2020-09-182020-09-221,960,784— $01,960,784SEC↗
DNI Denali Therapeutics Inc. J Other2019-08-082019-08-12400,000— $010,668,749SEC↗
FIXX Homology Medicines, Inc. J Other2019-05-212019-05-23300,001— $05,768,694SEC↗
SNNA Sienna Biopharmaceuticals, P Buy2019-02-222019-02-26150,000$2.50 $375.0K2,900,575SEC↗
SNNA Sienna Biopharmaceuticals, P Buy2019-02-222019-02-261,865,800$2.50 $4.66M1,865,800SEC↗
SNNA Sienna Biopharmaceuticals, P Buy2019-02-222019-02-26150,000$2.50 $375.0K1,032,493SEC↗
SRRK Scholar Rock Holding Corp C Conversion deriv2018-05-292018-05-31838,780— $00SEC↗
SRRK Scholar Rock Holding Corp C Conversion deriv2018-05-292018-05-311,811,595— $00SEC↗
SRRK Scholar Rock Holding Corp C Conversion deriv2018-05-292018-05-312,054,197— $00SEC↗
SRRK Scholar Rock Holding Corp C Conversion deriv2018-05-292018-05-311,249,999— $00SEC↗
SRRK Scholar Rock Holding Corp C Conversion deriv2018-05-292018-05-311,575,299— $00SEC↗
SRRK Scholar Rock Holding Corp C Conversion2018-05-292018-05-31551,807— $01,624,245SEC↗
SRRK Scholar Rock Holding Corp C Conversion2018-05-292018-05-31719,559— $02,343,804SEC↗
SRRK Scholar Rock Holding Corp C Conversion2018-05-292018-05-31293,813— $02,637,617SEC↗
SRRK Scholar Rock Holding Corp C Conversion2018-05-292018-05-31634,579— $01,072,438SEC↗
SRRK Scholar Rock Holding Corp C Conversion2018-05-292018-05-31437,859— $0437,859SEC↗
FIXX Homology Medicines, Inc. C Conversion deriv2018-04-022018-04-041,385,457— $00SEC↗
FIXX Homology Medicines, Inc. C Conversion deriv2018-04-022018-04-044,683,238— $00SEC↗
FIXX Homology Medicines, Inc. C Conversion2018-04-022018-04-046,068,695— $06,068,695SEC↗
DNLI Denali Therapeutics Inc. C Conversion deriv2017-12-122017-12-1210,068,749— $00SEC↗
DNLI Denali Therapeutics Inc. C Conversion deriv2017-12-122017-12-12375,000— $00SEC↗
DNLI Denali Therapeutics Inc. C Conversion deriv2017-12-122017-12-12312,500— $00SEC↗
DNLI Denali Therapeutics Inc. C Conversion2017-12-122017-12-1210,756,249— $011,068,749SEC↗
SNNA Sienna Biopharmaceuticals, C Conversion deriv2017-08-012017-08-01319,421— $00SEC↗
SNNA Sienna Biopharmaceuticals, C Conversion deriv2017-08-012017-08-012,538,641— $00SEC↗
SNNA Sienna Biopharmaceuticals, C Conversion deriv2017-08-012017-08-01563,072— $00SEC↗
SNNA Sienna Biopharmaceuticals, C Conversion deriv2017-08-012017-08-01211,934— $00SEC↗
SNNA Sienna Biopharmaceuticals, C Conversion2017-08-012017-08-01319,421— $0882,493SEC↗
SNNA Sienna Biopharmaceuticals, C Conversion2017-08-012017-08-01563,072— $0563,072SEC↗
SNNA Sienna Biopharmaceuticals, C Conversion2017-08-012017-08-01211,934— $02,750,575SEC↗
SNNA Sienna Biopharmaceuticals, C Conversion2017-08-012017-08-012,538,641— $02,538,641SEC↗